ICMR seeks participation for trial of plasma therapy for Covid-19 treatment

- The primary objective of the treatment will be to assess the safety and efficacy of convalescent plasma in treating Covid-19 patients
- Plasma from a cured patient is assumed to have antibodies against the virus and this can then be used to cure another patient